200 related articles for article (PubMed ID: 7685143)
1. [Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].
Kogawa T; Yanagiya H; Takashima T; Higashino I; Kudo T; Suzuki T; Mikuni T; Kido K; Tsukui A; Yagihashi Y
Hinyokika Kiyo; 1993 Mar; 39(3):281-7. PubMed ID: 7685143
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
Yoshida H; Haraguchi C; Ogawa Y; Kawai N; Ohyama M; Higaki Y; Saitoh T; Imamura K
Hinyokika Kiyo; 1983 Nov; 29(11):1419-26. PubMed ID: 6203377
[TBL] [Abstract][Full Text] [Related]
3. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method].
Shida K; Koyanagi T; Kawakura K; Nishida T; Kumamoto Y; Orikasa S; Sato S; Takeda M; Yamanaka H; Shimazaki J
Hinyokika Kiyo; 1986 Apr; 32(4):625-48. PubMed ID: 2426932
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
Murakoshi M; Ikada R; Tagawa M; Nakayama T
Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen changes as a result of chlormadinone acetate administration to patients with benign prostatic hyperplasia: a retrospective multi-institutional study.
Fujimoto K; Hirao Y; Masumori N; Arai Y; Yamanaka H; Kato T; Miyazawa K
Int J Urol; 2006 May; 13(5):543-9. PubMed ID: 16771723
[TBL] [Abstract][Full Text] [Related]
8. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
Murakoshi M; Ikeda R; Fukui N; Nakayama T
Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
[TBL] [Abstract][Full Text] [Related]
9. [Transurethral resection for prostatic adenoma larger than 100 ml--preoperative treatment with interstitial laser coagulation of the prostate plus chlormadinone acetate as a treatment maneuver for safer operations].
Furuya S; Furuya R; Ogura H; Shimamura S; Araki T
Hinyokika Kiyo; 2005 Mar; 51(3):159-64. PubMed ID: 15852668
[TBL] [Abstract][Full Text] [Related]
10. [Conservative treatment of benign prostatic hypertrophy--clinical effects of increased administration of Hachimijiogan and the relation between these effects and the "Sho" of Chinese medicine].
Yachiku S; Kaneko S; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1985 Mar; 31(3):545-51. PubMed ID: 2411117
[TBL] [Abstract][Full Text] [Related]
11. [Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
Umeda K
Hinyokika Kiyo; 1991 Nov; 37(11):1429-33. PubMed ID: 1722628
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effect of allylestrenol on benign prostatic hypertrophy].
Tajima A; Aso Y; Ushiyama T; Hata M; Kambayashi T; Ohmi Y; Masuda H; Nakahara M; Kitagawa M; Suzuki A
Hinyokika Kiyo; 1986 Mar; 32(3):477-85. PubMed ID: 2425610
[TBL] [Abstract][Full Text] [Related]
13. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effects of allylestrenol on prostatic hypertrophy].
Kohri K; Kurita T; Iguchi M; Kataoka K
Hinyokika Kiyo; 1986 Mar; 32(3):486-92. PubMed ID: 2425611
[TBL] [Abstract][Full Text] [Related]
15. Histological evaluation of benign prostatic hyperplasia treated by long-term administration of chlormadinone acetate (CMA).
Harada M; Kinoshita Y; Moriyama M; Kondo I; Nakahashi M; Kumagai H; Sasaki K; Hosaka M
Prostate; 1994 Sep; 25(3):147-55. PubMed ID: 7520578
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer: effects on lipid metabolism].
Shimada M; Uchida H; Kasahara T; Fuji K; Ogawa Y; Yoshida H; Hamajima T; Matsuda N; Ikeuchi T; Kai Y; Hiramori M; Hoshino M; Inoue K; Higaki Y
Hinyokika Kiyo; 1998 Jul; 44(7):525-32. PubMed ID: 9752613
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only].
Ueki O; Kawaguchi K; Katsumi T; Murayama K; Kameda K; Nishino A; Sakai A; Haginaka T; Miyazaki K; Asari T; Egawa M
Hinyokika Kiyo; 1998 Aug; 44(8):565-73. PubMed ID: 9783192
[TBL] [Abstract][Full Text] [Related]
18. [Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
Matsuura T; Wakabayashi A; Kaneko S; Kurita T
Hinyokika Kiyo; 1986 Jun; 32(6):903-6. PubMed ID: 2429533
[TBL] [Abstract][Full Text] [Related]
19. [The course and limitation of medical treatment for benign prostatic hyperplasia].
Kitagawa N; Akakura K; Akimoto S; Shimazaki J; Murakami S; Ishikawa T; Kataumi S; Sotoma T; Takagishi H; Kitamura Y
Hinyokika Kiyo; 1994 Sep; 40(9):781-8. PubMed ID: 7528462
[TBL] [Abstract][Full Text] [Related]
20. [Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].
Noguchi K; Uemura H; Takeda M; Sekiguchi Y; Ogawa K; Hosaka M
Hinyokika Kiyo; 2000 Sep; 46(9):605-7. PubMed ID: 11107528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
